Bavarian Nordic A/S (Bavarian Nordic A/S) Common Stock : $114 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Bavarian Nordic A/S Common Stock?

Bavarian Nordic A/S's quarterly common stock declined from Jun. 2023 ($113 Mil) to Sep. 2023 ($112 Mil) but then increased from Sep. 2023 ($112 Mil) to Dec. 2023 ($114 Mil).

Bavarian Nordic A/S's annual common stock declined from Dec. 2021 ($107 Mil) to Dec. 2022 ($101 Mil) but then increased from Dec. 2022 ($101 Mil) to Dec. 2023 ($114 Mil).

Bavarian Nordic A/S Common Stock Historical Data

The historical data trend for Bavarian Nordic A/S's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Common Stock Chart

Bavarian Nordic A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

48.18

95.58

107.08

100.72

114.27

Bavarian Nordic A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															100.72	112.01	113.40	111.52	114.27

Bavarian Nordic A/S Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

BVNKF:USA BAVAc:UK 0DPB:UK BAVA:Denmark BV3:Germany

Address

Philip Heymans Alle 3, Hellerup, DNK, DK-2900

Website

https://www.bavarian-nordic.com

Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.